All-cause mortality risk in older patients with femoral neck fracture.
Li XP, Zhang P, Zhu SW, Yang MH, Wu XB, Jiang XY.
Li XP, et al.
BMC Musculoskelet Disord. 2022 Oct 28;23(1):941. doi: 10.1186/s12891-022-05880-y.
BMC Musculoskelet Disord. 2022.
PMID: 36307783
Free PMC article.
Additionally, therapy with zoledronic acid 5 mg (Aclasta) was a protective factor (Li XP, Zhang P, Zhu SW, Yang MH, Wu XB, Jiang XY, J Orthop Surg Res. 16:727, 2021). ...
Additionally, therapy with zoledronic acid 5 mg (Aclasta) was a protective factor (Li XP, Zhang P, Zhu SW, Yang MH, Wu XB, Jia …